PHIAN Stock Chart & Stats
$479.54
$0.00(0.00%)
At close: 4:00 PM EDT
$479.54
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$330.00 - $504.33
Previous CloseN/A
Volume0.00
Average Volume (3M)421.00
Market Cap
$435.12B
Enterprise Value$28.72K
Total Cash (Recent Filing)$1.79B
Total Debt (Recent Filing)$7.46B
Price to Earnings (P/E)22.0
Beta0.50
Next Earnings
Nov 03, 2026EPS Estimate
7.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.17
Shares Outstanding982,884,770
10 Day Avg. Volume1,264
30 Day Avg. Volume421
Financial Highlights & Ratios
PEG Ratio-0.11
Price to Book (P/B)2.01
Price to Sales (P/S)1.24
P/FCF Ratio24.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$532.69Price Target Upside11.08% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)31.83
Revenue Forecast (FY)$357.91B
Bulls Say, Bears Say
Bulls Say
Profitability RecoveryPhilips returned to profitability with healthy revenue growth and positive operating margins in the TTM period. Sustained positive net and EBIT margins alongside revenue recovery improve capacity to fund R&D, services and capital investments, supporting durable earnings generation over months.
Manageable Balance SheetLeverage sits at a moderate level with substantial equity and broadly stable historical ranges, giving Philips resilience to absorb shocks and fund strategic initiatives. A solid equity base and manageable debt enhance flexibility for capex, servicing installed base and selective M&A over the medium term.
Recurring Service Revenue & InnovationPhilips benefits from an installed-base-driven recurring revenue model (services, upgrades, software subscriptions and consumables). Continued regulatory clearances and product launches (e.g., SpO2 sensor) support platform stickiness and recurring monetisation, reinforcing medium-term revenue durability.
Bears Say
Weak Free Cash Flow GrowthAlthough absolute operating and free cash flows are positive, the sharp TTM decline in FCF growth undermines cash-conversion reliability. Persistent swings in cash generation constrain reinvestment, debt reduction or shareholder returns unless operational consistency improves over coming quarters.
Earnings Volatility & Below-peak MarginsHistorical volatility in margins and earnings reduces visibility into sustainable profitability. Lower-than-peak margins and recent multi-year swings mean future profitability depends on sustained execution, making long-term margin durability and forecasting less certain across business cycles.
Lumpy Hospital Procurement RisksReliance on hospital capital purchases and tender-driven sales creates timing and order concentration risk, producing lumpy revenue and service demand. This structural exposure can amplify working-capital swings, complicate cash flow predictability and lengthen revenue realization over quarters.
PHIAN FAQ
What was Koninklijke Philips N.V.’s price range in the past 12 months?
Koninklijke Philips N.V. lowest stock price was $330.00 and its highest was $504.33 in the past 12 months.
What is Koninklijke Philips N.V.’s market cap?
Koninklijke Philips N.V.’s market cap is $435.12B.
When is Koninklijke Philips N.V.’s upcoming earnings report date?
Koninklijke Philips N.V.’s upcoming earnings report date is Nov 03, 2026 which is in 96 days.
How were Koninklijke Philips N.V.’s earnings last quarter?
Koninklijke Philips N.V. released its earnings results on Jul 27, 2026. The company reported $9.788 earnings per share for the quarter, beating the consensus estimate of $7.032 by $2.757.
Is Koninklijke Philips N.V. overvalued?
According to Wall Street analysts Koninklijke Philips N.V.’s price is currently Undervalued.
Does Koninklijke Philips N.V. pay dividends?
Koninklijke Philips N.V. does not currently pay dividends.
What is Koninklijke Philips N.V.’s EPS estimate?
Koninklijke Philips N.V.’s EPS estimate is 7.33.
How many shares outstanding does Koninklijke Philips N.V. have?
Koninklijke Philips N.V. has 982,884,770 shares outstanding.
What happened to Koninklijke Philips N.V.’s price movement after its last earnings report?
Koninklijke Philips N.V. reported an EPS of $9.788 in its last earnings report, beating expectations of $7.032. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Koninklijke Philips N.V.?
Currently, no hedge funds are holding shares in MX:PHIAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Koninklijke Philips N.V.
Koninklijke Philips N.V. operates as a leading global healthcare technology enterprise with a presence across North America and numerous international markets. Its operations are organized into three primary divisions: Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses. Within the Diagnosis & Treatment segment, Philips offers advanced diagnostic imaging technologies, including magnetic resonance (MRI), computed tomography (CT), X-ray systems, and innovative detector-based spectral CT solutions, alongside molecular and hybrid imaging for nuclear medicine. The company also provides integrated interventional systems and comprehensive echography (ultrasound) solutions, crucial for diagnosis, treatment planning, and guidance in areas like cardiology, general imaging, obstetrics/gynecology, and point-of-care settings. This segment is further supported by proprietary software platforms designed to facilitate diagnostics and interventions, as well as enterprise diagnostic informatics products and related services. The Connected Care division focuses on solutions for critical patient management, emergency response, and sleep and respiratory conditions. Additionally, it delivers electronic medical record (EMR) and broader care management platforms. For Personal Health, Philips provides a range of consumer products, encompassing oral hygiene solutions such as electric toothbrushes, brush heads, and interdental cleaning and teeth whitening systems. This segment also includes infant feeding and digital parenting solutions, along with male grooming and beauty devices. Philips actively pursues strategic collaborations to enhance its offerings, notably partnering with Ibex Medical Analytics Ltd. to jointly promote digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide. The company also maintains a strategic partnership agreement with NICO.LAB. Established in 1891 and headquartered in Amsterdam, the Netherlands, the company adopted its current name, Koninklijke Philips N.V., in May 2013, having previously operated as Koninklijke Philips Electronics N.V.
PHIAN Stock 12 Month Forecast
Average Price Target
$532.69
▲(11.08% Upside)